Short Interest in AquaBounty Technologies, Inc. (NASDAQ:AQB) Expands By 452.6%

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 423,300 shares, a growth of 452.6% from the December 31st total of 76,600 shares. Currently, 11.7% of the shares of the stock are short sold. Based on an average trading volume of 425,500 shares, the short-interest ratio is currently 1.0 days.

Institutional Trading of AquaBounty Technologies

An institutional investor recently raised its position in AquaBounty Technologies stock. Epiq Partners LLC grew its holdings in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the period. Epiq Partners LLC owned approximately 2.30% of AquaBounty Technologies worth $56,000 at the end of the most recent quarter. 8.92% of the stock is owned by hedge funds and other institutional investors.

AquaBounty Technologies Stock Down 14.3 %

Shares of NASDAQ AQB opened at $0.70 on Wednesday. The company has a current ratio of 3.02, a quick ratio of 2.98 and a debt-to-equity ratio of 0.05. AquaBounty Technologies has a 12-month low of $0.47 and a 12-month high of $2.79. The firm’s 50-day moving average price is $0.80 and its 200-day moving average price is $1.07. The stock has a market capitalization of $2.71 million, a price-to-earnings ratio of -0.04 and a beta of 1.17.

AquaBounty Technologies (NASDAQ:AQB) last issued its quarterly earnings data on Tuesday, November 5th. The company reported ($0.88) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.88). The business had revenue of $0.05 million for the quarter, compared to the consensus estimate of $0.10 million. AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. During the same period in the prior year, the business posted ($1.60) earnings per share.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.